Principal Financial Group Inc. cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 29.1% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 475,089 shares of the company’s stock after selling 194,775 shares during the period. Principal Financial Group Inc.’s holdings in Option Care Health were worth $14,870,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in OPCH. UMB Bank n.a. lifted its stake in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after acquiring an additional 750 shares during the last quarter. GAMMA Investing LLC lifted its stake in Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its stake in Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after acquiring an additional 1,446 shares during the last quarter. Blue Trust Inc. lifted its stake in Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares during the last quarter. Finally, SageView Advisory Group LLC acquired a new stake in Option Care Health in the first quarter valued at approximately $85,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on the stock. Barrington Research reduced their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. JMP Securities boosted their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Finally, Truist Financial reduced their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $30.83.
Insider Transactions at Option Care Health
In related news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 8.58 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is owned by insiders.
Option Care Health Stock Down 1.2 %
OPCH opened at $21.93 on Friday. The firm’s 50-day simple moving average is $28.82 and its 200-day simple moving average is $29.44. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a twelve month low of $21.64 and a twelve month high of $34.63. The firm has a market cap of $3.73 billion, a price-to-earnings ratio of 18.65, a PEG ratio of 2.30 and a beta of 1.32.
Option Care Health Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
- Five stocks we like better than Option Care Health
- Retail Stocks Investing, Explained
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Top-Performing Non-Leveraged ETFs This Year
- 3 Tickers Leading a Meme Stock Revival
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.